| For: | Cacoub P, Ouzan D, Melin P, Lang JP, Rotily M, Fontanges T, Varastet M, Chousterman M, Marcellin P. Patient education improves adherence to peg-interferon and ribavirin in chronic genotype 2 or 3 hepatitis C virus infection: A prospective, real-life, observational study. World J Gastroenterol 2008; 14(40): 6195-6203 [PMID: 18985810 DOI: 10.3748/wjg.14.6195] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i40/6195.htm |
| Number | Citing Articles |
| 1 |
J. Hugueny, P. Fagnoni, M.-H. Guignard. Prise en charge de l’hépatite C chronique : les dernières avancées thérapeutiques. Le Pharmacien Hospitalier et Clinicien 2013; 48(2) doi: 10.1016/j.phclin.2012.08.003
|
| 2 |
Kali Zhou, Thomas Fitzpatrick, Nick Walsh, Ji Young Kim, Roger Chou, Mellanye Lackey, Julia Scott, Ying-Ru Lo, Joseph D Tucker. Interventions to optimise the care continuum for chronic viral hepatitis: a systematic review and meta-analyses. The Lancet Infectious Diseases 2016; 16(12) doi: 10.1016/S1473-3099(16)30208-0
|
| 3 |
Jason Grebely, Gail V. Matthews, Margaret Hellard, David Shaw, Ingrid van Beek, Kathy Petoumenos, Maryam Alavi, Barbara Yeung, Paul S. Haber, Andrew R. Lloyd, John M. Kaldor, Gregory J. Dore. Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users. Journal of Hepatology 2011; 55(1) doi: 10.1016/j.jhep.2010.10.033
|
| 4 |
Dominique Larrey, Annie Salse, Didier Ribard, Olivier Boutet, Valérie Hyrailles–Blanc, Birame Niang, Georges Philippe Pageaux, Emmanuel Vaucher, Jean Pierre Arpurt, Guy Boulay, Natalia Karlova, Jean Pierre Daures. Education by a Nurse Increases Response of Patients With Chronic Hepatitis C to Therapy With Peginterferon-α2a and Ribavirin. Clinical Gastroenterology and Hepatology 2011; 9(9) doi: 10.1016/j.cgh.2011.05.022
|
| 5 |
Pyung Gohn Goh, Min Jung Kim, Hye Jin Kim, Hyuk Soo Eun, Eui Sik Kim, Yun Jeung Kim, Soo Youn Lee, Hee Seok Moon, Eaum Seok Lee, Seok Hyun Kim, Byung Seok Lee, Heon Young Lee. Importance of Medication Adherence to Peginterferon-Ribavirin Combination Therapy in Patients with Chronic Hepatitis C. The Korean Journal of Gastroenterology 2011; 57(5) doi: 10.4166/kjg.2011.57.5.294
|
| 6 |
Samali Lubega, Uchenna Agbim, Miranda Surjadi, Megan Mahoney, Mandana Khalili. Formal hepatitis C education enhances HCV care coordination, expedites HCV treatment and improves antiviral response. Liver International 2013; 33(7) doi: 10.1111/liv.12150
|
| 7 |
Patrizia Burra, Giacomo Germani, Francesca Gnoato, Silvia Lazzaro, Francesco Paolo Russo, Umberto Cillo, Marco Senzolo. Adherence in Liver Transplant Recipients. Liver Transplantation 2011; 17(7) doi: 10.1002/lt.22294
|
| 8 |
Chung Hyun Tae, Sung-Ae Jung, Hye Sung Moon, Jung-A Seo, Hye Kyung Song, Chang Mo Moon, Seong-Eun Kim, Ki-Nam Shim, Hye-Kyung Jung. Importance of Patients’ Knowledge of Their Prescribed Medication in Improving Treatment Adherence in Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 2016; 50(2) doi: 10.1097/MCG.0000000000000431
|
| 9 |
Li-Li Jiang, Qing Wang, Jia-Xin Zhang, Jing-Hui Fan, Jing Li. Advances in clinical application on nursing intervention for ribavirin-associated adverse events. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1596007
|
| 10 |
Saeedeh Ravi, Mohsen Nasiri Toosi, Iman Karimzadeh, Mehdi Ahadi-Barzoki, Hossein Khalili. Adherence to Chronic Hepatitis C Treatment Regimen: First Report From a Referral Center in Iran. Hepatitis Monthly 2013; 13(6) doi: 10.5812/hepatmon.11038
|
| 11 |
Şengül Korkmaz Binay, Aylin Özakgül. Effect of education on oral antiviral use on medication adherence and quality of life in patients with chronic hepatitis B: a randomised trial. Journal of Research in Nursing 2026; doi: 10.1177/17449871261462853
|
| 12 |
|
| 13 |
Rhoda R. Redulla, K. Rajender Reddy, Thomas W. Faust, Sharon Dudley-Brown. Project P.E.A.C.H. (Pathway and Education Toward Adherence and Completion in Hepatitis C Therapy). Gastroenterology Nursing 2015; 38(5) doi: 10.1097/SGA.0000000000000166
|
| 14 |
J. J. WEISS, N. BRÄU, A. STIVALA, T. SWAN, D. FISHBEIN. Review article: adherence to medication for chronic hepatitis C – building on the model of human immunodeficiency virus antiretroviral adherence research. Alimentary Pharmacology & Therapeutics 2009; 30(1) doi: 10.1111/j.1365-2036.2009.04004.x
|
| 15 |
A. Brett Hauber, A. F. Mohamed, C. Beam, J. Medjedovic, J. Mauskopf. Patient preferences and assessment of likely adherence to hepatitis C virus treatment. Journal of Viral Hepatitis 2011; 18(9) doi: 10.1111/j.1365-2893.2010.01343.x
|
| 16 |
Joanne LaFleur, Robert Hoop, Eli Korner, Scott DuVall, Timothy Morgan, Prashant Pandya, Jian Han, Kristin Knippenberg, Richard E. Nelson. Predictors of Early Discontinuation of Pegylated Interferon for Reasons Other Than Lack of Efficacy in United States Veterans With Chronic Hepatitis C. Gastroenterology Nursing 2015; 38(6) doi: 10.1097/SGA.0000000000000214
|
| 17 |
Dominique Salmon‐Ceron, Cédric Arvieux, Marc Bourlière, Patrice Cacoub, Philippe Halfon, Karine Lacombe, Georges‐Philippe Pageaux, Gilles Pialoux, Lionel Piroth, Isabelle Poizot‐Martin, Eric Rosenthal, Stanislas Pol. Use of first‐generationHCVprotease inhibitors in patients coinfected byHIVandHCVgenotype 1. Liver International 2014; 34(6) doi: 10.1111/liv.12363
|
| 18 |
Sheila A. Williams. Nursing Interventions on Medication Adherence During Hepatitis C Treatment. Gastroenterology Nursing 2018; 41(6) doi: 10.1097/SGA.0000000000000362
|
| 19 |
Claus Niederau, Stefan Mauss, Andreas Schober, Albrecht Stoehr, Tim Zimmermann, Michael Waizmann, Gero Moog, Stefan Pape, Bernd Weber, Konrad Isernhagen, Petra Sandow, Bernd Bokemeyer, Ulrich Alshuth, Hermann Steffens, Dietrich Hüppe, Partha Mukhopadhyay. Predictive Factors for Sustained Virological Response after Treatment with Pegylated Interferon α-2a and Ribavirin in Patients Infected with HCV Genotypes 2 and 3. PLoS ONE 2014; 9(9) doi: 10.1371/journal.pone.0107592
|
| 20 |
Amber Arain, Jessica De Sousa, Kirsten Corten, Rita Verrando, Herbert Thijs, Catharina Mathei, Frank Buntinx, Geert Robaeys. Pilot Study: Combining Formal and Peer Education with FibroScan to Increase HCV Screening and Treatment in Persons who use Drugs. Journal of Substance Abuse Treatment 2016; 67 doi: 10.1016/j.jsat.2016.04.001
|
| 21 |
Rhoda Redulla, Sharon Dudley-Brown. Adherence and Completion in Hepatitis C Management. Gastroenterology Nursing 2013; 36(1) doi: 10.1097/SGA.0b013e318281634e
|
| 22 |
Saeedeh Ravi, Mohsen Nasiri-Toosi, Iman Karimzadeh, Hossein Khalili, Mehdi Ahadi-Barzoki, Simin Dashti-Khavidaki. Pattern and associated factors of anti-hepatitis C virus treatment-induced adverse reactions. Expert Opinion on Drug Safety 2014; 13(3) doi: 10.1517/14740338.2014.866091
|
| 23 |
Juliette Bernard-Leclerc, Ornella Conort, Yannick Bacq, Daniel Antier. Impact d’un programme d’éducation thérapeutique sur les connaissances, l’observance et la satisfaction des patients traités pour hépatite chronique virale C. Education Thérapeutique du Patient - Therapeutic Patient Education 2011; 3(1) doi: 10.1051/tpe/2011104
|
| 24 |
Adi V. Gundlapalli, Richard E. Nelson, Candace Haroldsen, Marjorie E. Carter, Joanne LaFleur, Naglaa H. Shoukry. Correlates of Initiation of Treatment for Chronic Hepatitis C Infection in United States Veterans, 2004–2009. PLOS ONE 2015; 10(7) doi: 10.1371/journal.pone.0132056
|
| 25 |
Sheila Williams. Impact of Nursing Interventions on Medication Adherence During Hepatitis C Treatment. Gastroenterology Nursing 2018; 41(5) doi: 10.1097/SGA.0000000000000327
|
| 26 |
D. M. Evon, D. A. Esserman, J. E. Bonner, T. Rao, M. W. Fried, C. E. Golin. Adherence toPEG/ribavirin treatment for chronic hepatitis C: prevalence, patterns, and predictors of missed doses and nonpersistence. Journal of Viral Hepatitis 2013; 20(8) doi: 10.1111/jvh.12079
|